Dr Aaron Robert Perkins, PHARMD - Pharmacist in Murray, KY

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

News Archive

Milestone study could impact standard guidelines for stroke treatment

Standard guidelines for stroke treatment currently recommend clot removal only within six hours of stroke onset. But a milestone study with results published today in the New England Journal of Medicine shows that clot removal up to 24 hours after stroke led to significantly reduced disability for properly selected patients.

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

Tibotec presents TMC435 phase 2b study interim results against HCV at EASL meeting

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces that their partner, Tibotec has presented the results of a planned Week 24 interim analysis of the phase 2b ASPIRE study for TMC435 in treatment experienced hepatitis C patients in a late-breaker session at the 46th Annual meeting of the European Association for the Study of the Liver, Berlin, Germany.

Officials investigate if use of surgical robot led to injuries

The Wall Street Journal: Injuries at a small New Hampshire hospital that uses a surgical robot have some questioning the use of such machines in the care of people. The machine, which is named after Leonardo da Vinci, has been linked to surgeries where patients have been hurt, including two with lacerated bladders and one woman who required four subsequent surgeries after errors using the machine.

DAWN trial: Mechanical thrombectomy plus medication significantly decreases post-stroke disability

Results from the DAWN stroke trial presented at the European Stroke Organization Conference provide compelling evidence that selected patients suffering a major ischemic stroke recovered significantly better with mechanical retrieval of the blood clot with medical therapy compared with medical therapy alone when initiated past the current guidelines of within 6 hours and up to 24 hours of the stroke.

Read more News

› Verified 3 days ago